+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Atypical Antipsychotic Treatment Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type- Product Image
Atypical Antipsychotic Treatment Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type- Product Image
New

Atypical Antipsychotic Treatment Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

  • PDF Icon

    Report

  • 91 Pages
  • January 2025
  • Region: Global
  • Prof Research
  • ID: 5726294
Description Jump to:
The Atypical Antipsychotic Treatment Market has established itself as a crucial segment within the broader pharmaceuticals sector, driven by the increasing prevalence of mental health disorders and growing awareness surrounding mental health treatment options. Atypical antipsychotics are pivotal in managing conditions such as schizophrenia, bipolar disorder, and major depressive disorder. They offer benefits over conventional antipsychotics, particularly regarding side effects and patient tolerability.

Market Overview

The atypical antipsychotic treatment market is poised for substantial growth from 2025 to 2030. Factors contributing to this growth include rising mental health disorder incidences, advancements in drug formulations, and increasing investments in research and development (R&D). The need for more effective treatment options that minimize side effects presents a lucrative opportunity for manufacturers. With a focus on patient-centric care, the market is slowly shifting towards innovative delivery systems such as long-acting injectables.

Market Size and Trends

According to recent reports, the atypical antipsychotic treatment market was valued at approximately $17.5 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 6.1% during the forecast period (20252030), aiming to reach around $24 billion by the end of this period.

Share and Trends Analysis

By Product Type

  • Aripiprazole: This is a leading product in the market due to its effectiveness and favorable side effect profile.
  • Paliperidone Palmitate: Known for its long-acting injectable form, it is gaining traction in patient adherence.
  • Aripiprazole Lauroxil: This newer formulation is also contributing to increased market share.
  • Olanzapine: An established player, although facing some competition from novel therapies.
  • Cariprazine: Recognized for its unique mechanism of action, it is on an upward trend.
  • Lumateperone: A recent market entrant that is being investigated for various mental health applications.
  • Lurasidone: Known for its approval in bipolar depression, it is expanding its market presence.
  • Others: This category includes various generic drugs and novel treatments that are under clinical trials.

By Key Players

  • Otsuka Holdings
  • Johnson & Johnson
  • Alkermes
  • Eli Lilly
  • Allergan
  • Intra-Cellular Therapies
  • Sumitomo Dainippon Pharma
These companies are actively pursuing strategic partnerships and acquisitions to strengthen their product portfolios and enhance market reach. Ongoing R&D efforts aim to develop more effective formulations with lowered side effects, catering to a broader spectrum of patient needs.

By Process

The atypical antipsychotic treatment market is primarily characterized by pharmaceutical processes such as:
  • Formulation Development: Continuous innovation in drug formulations to enhance patient compliance.
  • Manufacturing: Advancements in manufacturing techniques to reduce costs and improve drug availability.
  • Clinical Trials: Ongoing research to prove the efficacy and safety of new drug formulations.

By Application

The primary applications of atypical antipsychotic treatments include:
  • Schizophrenia: The largest application segment due to the need for effective long-term management.
  • Bipolar Disorder: Growing recognition of the condition leads to increased therapeutic use.
  • Major Depressive Disorder: Certain atypical antipsychotics are gaining acceptance as adjunct therapies.

By End-Use

The end-use segment of the market includes:
  • Hospitals: The largest end-use sector, providing treatment to acute patients.
  • Clinics: Outpatient care facilities utilizing a range of atypical antipsychotics.
  • Homecare Settings: An emerging segment with the increase in telehealth and home-based care options.

Regional Analysis

The market is segmented by region into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa:
  • North America: Dominates the market due to high healthcare expenditure, advanced healthcare infrastructure, and increasing awareness regarding mental health.
  • Europe: Follows closely, with a strong focus on innovative treatments and favorable regulatory policies.
  • Asia-Pacific: Projected to experience robust growth because of increasing incidences of mental health disorders, improving healthcare systems, and rising consumer awareness.
  • Latin America: Gaining momentum due to an increase in investment in healthcare and mental health initiatives by governments.
  • Middle East & Africa: The market is growing with rising awareness and significant initiatives to tackle mental health issues.

Market News on Policy and Companies

Significant efforts are being made by governments across the globe to address mental health through policy initiatives. In 2023, the World Health Organization (WHO) launched various campaigns to promote mental health, prompting increased funding for antipsychotic treatments.

In recent instances, key players like Johnson & Johnson and Eli Lilly have significantly invested in R&D, with new drug candidates entering late-stage trials. Furthermore, ongoing collaborations between pharmaceutical companies and academic institutions are focused on developing next-generation atypical antipsychotics.

Additionally, biosimilars and generics are increasingly attributed to lowering healthcare costs, which influences prescribing patterns within the community.

Segment Forecasts (2025 - 2030)

As we forecast through 2025 to 2030, the market is expected to evolve substantially:
  • Product Type Growth: Aripiprazole and paliperidone palmitate will likely retain significant market shares, while newer entrants like cariprazine and lumateperone may capture a growing segment of the market.
  • Key Player Initiatives: Companies focusing on patient access programs and medication adherence strategies will emerge as market leaders.
  • Region-Specific Developments: North America will continue to lead in market size, while Asia-Pacific is expected to showcase the fastest growth due to untapped opportunities in mental health care.
Furthermore, growing trends towards personalized medicine and tailored therapeutic options will shape future market dynamics.

Conclusion

The Atypical Antipsychotic Treatment Market is entering a phase of robust growth characterized by innovation, increased awareness, and a strong focus on patient-centric approaches. Stakeholders across the value chain must leverage opportunities to enhance treatment accessibility and effectiveness.

The market's outlook through 2030 underscores the importance of continued investment in R&D and the need to address evolving patient needs in a landscape increasingly focused on mental health. The active engagement of regulatory authorities and healthcare practitioners will facilitate the growth trajectory of this critical market segment.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Atypical Antipsychotic Treatment Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Atypical Antipsychotic Treatment Market in North America (2020-2030)
8.1 Atypical Antipsychotic Treatment Market Size
8.2 Atypical Antipsychotic Treatment Market by End Use
8.3 Competition by Players/Suppliers
8.4 Atypical Antipsychotic Treatment Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Atypical Antipsychotic Treatment Market in South America (2020-2030)
9.1 Atypical Antipsychotic Treatment Market Size
9.2 Atypical Antipsychotic Treatment Market by End Use
9.3 Competition by Players/Suppliers
9.4 Atypical Antipsychotic Treatment Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Atypical Antipsychotic Treatment Market in Asia & Pacific (2020-2030)
10.1 Atypical Antipsychotic Treatment Market Size
10.2 Atypical Antipsychotic Treatment Market by End Use
10.3 Competition by Players/Suppliers
10.4 Atypical Antipsychotic Treatment Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Atypical Antipsychotic Treatment Market in Europe (2020-2030)
11.1 Atypical Antipsychotic Treatment Market Size
11.2 Atypical Antipsychotic Treatment Market by End Use
11.3 Competition by Players/Suppliers
11.4 Atypical Antipsychotic Treatment Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Atypical Antipsychotic Treatment Market in MEA (2020-2030)
12.1 Atypical Antipsychotic Treatment Market Size
12.2 Atypical Antipsychotic Treatment Market by End Use
12.3 Competition by Players/Suppliers
12.4 Atypical Antipsychotic Treatment Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Atypical Antipsychotic Treatment Market (2020-2025)
13.1 Atypical Antipsychotic Treatment Market Size
13.2 Atypical Antipsychotic Treatment Market by End Use
13.3 Competition by Players/Suppliers
13.4 Atypical Antipsychotic Treatment Market Size by Type
Chapter 14 Global Atypical Antipsychotic Treatment Market Forecast (2025-2030)
14.1 Atypical Antipsychotic Treatment Market Size Forecast
14.2 Atypical Antipsychotic Treatment Application Forecast
14.3 Competition by Players/Suppliers
14.4 Atypical Antipsychotic Treatment Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Otsuka Holdings
15.1.1 Company Profile
15.1.2 Main Business and Atypical Antipsychotic Treatment Information
15.1.3 SWOT Analysis of Otsuka Holdings
15.1.4 Otsuka Holdings Atypical Antipsychotic Treatment Revenue, Gross Margin and Market Share (2020-2025)
15.2 Johnson & Johnson
15.2.1 Company Profile
15.2.2 Main Business and Atypical Antipsychotic Treatment Information
15.2.3 SWOT Analysis of Johnson & Johnson
15.2.4 Johnson & Johnson Atypical Antipsychotic Treatment Revenue, Gross Margin and Market Share (2020-2025)
15.3 Alkermes
15.3.1 Company Profile
15.3.2 Main Business and Atypical Antipsychotic Treatment Information
15.3.3 SWOT Analysis of Alkermes
15.3.4 Alkermes Atypical Antipsychotic Treatment Revenue, Gross Margin and Market Share (2020-2025)
15.4 Eli Lilly
15.4.1 Company Profile
15.4.2 Main Business and Atypical Antipsychotic Treatment Information
15.4.3 SWOT Analysis of Eli Lilly
15.4.4 Eli Lilly Atypical Antipsychotic Treatment Revenue, Gross Margin and Market Share (2020-2025)
15.5 Allergan
15.5.1 Company Profile
15.5.2 Main Business and Atypical Antipsychotic Treatment Information
15.5.3 SWOT Analysis of Allergan
15.5.4 Allergan Atypical Antipsychotic Treatment Revenue, Gross Margin and Market Share (2020-2025)
15.6 Intra-Cellular Therapies
15.6.1 Company Profile
15.6.2 Main Business and Atypical Antipsychotic Treatment Information
15.6.3 SWOT Analysis of Intra-Cellular Therapies
15.6.4 Intra-Cellular Therapies Atypical Antipsychotic Treatment Revenue, Gross Margin and Market Share (2020-2025)
15.7 Sumitomo Dainippon Pharma
15.7.1 Company Profile
15.7.2 Main Business and Atypical Antipsychotic Treatment Information
15.7.3 SWOT Analysis of Sumitomo Dainippon Pharma
15.7.4 Sumitomo Dainippon Pharma Atypical Antipsychotic Treatment Revenue, Gross Margin and Market Share (2020-2025)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Atypical Antipsychotic Treatment Report
Table Data Sources of Atypical Antipsychotic Treatment Report
Table Major Assumptions of Atypical Antipsychotic Treatment Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Atypical Antipsychotic Treatment Picture
Table Atypical Antipsychotic Treatment Classification
Table Atypical Antipsychotic Treatment Applications
Table Drivers of Atypical Antipsychotic Treatment Market
Table Restraints of Atypical Antipsychotic Treatment Market
Table Opportunities of Atypical Antipsychotic Treatment Market
Table Threats of Atypical Antipsychotic Treatment Market
Table COVID-19 Impact For Atypical Antipsychotic Treatment Market
Table Raw Materials Suppliers
Table Different Production Methods of Atypical Antipsychotic Treatment
Table Cost Structure Analysis of Atypical Antipsychotic Treatment
Table Key End Users
Table Latest News of Atypical Antipsychotic Treatment Market
Table Merger and Acquisition
Table Planned/Future Project of Atypical Antipsychotic Treatment Market
Table Policy of Atypical Antipsychotic Treatment Market
Table 2020-2030 North America Atypical Antipsychotic Treatment Market Size
Figure 2020-2030 North America Atypical Antipsychotic Treatment Market Size and CAGR
Table 2020-2030 North America Atypical Antipsychotic Treatment Market Size by Application
Table 2020-2025 North America Atypical Antipsychotic Treatment Key Players Revenue
Table 2020-2025 North America Atypical Antipsychotic Treatment Key Players Market Share
Table 2020-2030 North America Atypical Antipsychotic Treatment Market Size by Type
Table 2020-2030 United States Atypical Antipsychotic Treatment Market Size
Table 2020-2030 Canada Atypical Antipsychotic Treatment Market Size
Table 2020-2030 Mexico Atypical Antipsychotic Treatment Market Size
Table 2020-2030 South America Atypical Antipsychotic Treatment Market Size
Figure 2020-2030 South America Atypical Antipsychotic Treatment Market Size and CAGR
Table 2020-2030 South America Atypical Antipsychotic Treatment Market Size by Application
Table 2020-2025 South America Atypical Antipsychotic Treatment Key Players Revenue
Table 2020-2025 South America Atypical Antipsychotic Treatment Key Players Market Share
Table 2020-2030 South America Atypical Antipsychotic Treatment Market Size by Type
Table 2020-2030 Brazil Atypical Antipsychotic Treatment Market Size
Table 2020-2030 Argentina Atypical Antipsychotic Treatment Market Size
Table 2020-2030 Chile Atypical Antipsychotic Treatment Market Size
Table 2020-2030 Peru Atypical Antipsychotic Treatment Market Size
Table 2020-2030 Asia & Pacific Atypical Antipsychotic Treatment Market Size
Figure 2020-2030 Asia & Pacific Atypical Antipsychotic Treatment Market Size and CAGR
Table 2020-2030 Asia & Pacific Atypical Antipsychotic Treatment Market Size by Application
Table 2020-2025 Asia & Pacific Atypical Antipsychotic Treatment Key Players Revenue
Table 2020-2025 Asia & Pacific Atypical Antipsychotic Treatment Key Players Market Share
Table 2020-2030 Asia & Pacific Atypical Antipsychotic Treatment Market Size by Type
Table 2020-2030 China Atypical Antipsychotic Treatment Market Size
Table 2020-2030 India Atypical Antipsychotic Treatment Market Size
Table 2020-2030 Japan Atypical Antipsychotic Treatment Market Size
Table 2020-2030 South Korea Atypical Antipsychotic Treatment Market Size
Table 2020-2030 Southeast Asia Atypical Antipsychotic Treatment Market Size
Table 2020-2030 Australia Atypical Antipsychotic Treatment Market Size
Table 2020-2030 Europe Atypical Antipsychotic Treatment Market Size
Figure 2020-2030 Europe Atypical Antipsychotic Treatment Market Size and CAGR
Table 2020-2030 Europe Atypical Antipsychotic Treatment Market Size by Application
Table 2020-2025 Europe Atypical Antipsychotic Treatment Key Players Revenue
Table 2020-2025 Europe Atypical Antipsychotic Treatment Key Players Market Share
Table 2020-2030 Europe Atypical Antipsychotic Treatment Market Size by Type
Table 2020-2030 Germany Atypical Antipsychotic Treatment Market Size
Table 2020-2030 France Atypical Antipsychotic Treatment Market Size
Table 2020-2030 United Kingdom Atypical Antipsychotic Treatment Market Size
Table 2020-2030 Italy Atypical Antipsychotic Treatment Market Size
Table 2020-2030 Spain Atypical Antipsychotic Treatment Market Size
Table 2020-2030 Belgium Atypical Antipsychotic Treatment Market Size
Table 2020-2030 Netherlands Atypical Antipsychotic Treatment Market Size
Table 2020-2030 Austria Atypical Antipsychotic Treatment Market Size
Table 2020-2030 Poland Atypical Antipsychotic Treatment Market Size
Table 2020-2030 Russia Atypical Antipsychotic Treatment Market Size
Table 2020-2030 MEA Atypical Antipsychotic Treatment Market Size
Figure 2020-2030 MEA Atypical Antipsychotic Treatment Market Size and CAGR
Table 2020-2030 MEA Atypical Antipsychotic Treatment Market Size by Application
Table 2020-2025 MEA Atypical Antipsychotic Treatment Key Players Revenue
Table 2020-2025 MEA Atypical Antipsychotic Treatment Key Players Market Share
Table 2020-2030 MEA Atypical Antipsychotic Treatment Market Size by Type
Table 2020-2030 Egypt Atypical Antipsychotic Treatment Market Size
Table 2020-2030 Israel Atypical Antipsychotic Treatment Market Size
Table 2020-2030 South Africa Atypical Antipsychotic Treatment Market Size
Table 2020-2030 Gulf Cooperation Council Countries Atypical Antipsychotic Treatment Market Size
Table 2020-2030 Turkey Atypical Antipsychotic Treatment Market Size
Table 2020-2025 Global Atypical Antipsychotic Treatment Market Size by Region
Table 2020-2025 Global Atypical Antipsychotic Treatment Market Size Share by Region
Table 2020-2025 Global Atypical Antipsychotic Treatment Market Size by Application
Table 2020-2025 Global Atypical Antipsychotic Treatment Market Share by Application
Table 2020-2025 Global Atypical Antipsychotic Treatment Key Vendors Revenue
Figure 2020-2025 Global Atypical Antipsychotic Treatment Market Size and Growth Rate
Table 2020-2025 Global Atypical Antipsychotic Treatment Key Vendors Market Share
Table 2020-2025 Global Atypical Antipsychotic Treatment Market Size by Type
Table 2020-2025 Global Atypical Antipsychotic Treatment Market Share by Type
Table 2025-2030 Global Atypical Antipsychotic Treatment Market Size by Region
Table 2025-2030 Global Atypical Antipsychotic Treatment Market Size Share by Region
Table 2025-2030 Global Atypical Antipsychotic Treatment Market Size by Application
Table 2025-2030 Global Atypical Antipsychotic Treatment Market Share by Application
Table 2025-2030 Global Atypical Antipsychotic Treatment Key Vendors Revenue
Figure 2025-2030 Global Atypical Antipsychotic Treatment Market Size and Growth Rate
Table 2025-2030 Global Atypical Antipsychotic Treatment Key Vendors Market Share
Table 2025-2030 Global Atypical Antipsychotic Treatment Market Size by Type
Table 2025-2030 Atypical Antipsychotic Treatment Global Market Share by Type

Companies Mentioned

  • Otsuka Holdings
  • Johnson & Johnson
  • Alkermes
  • Eli Lilly
  • Allergan
  • Intra-Cellular Therapies
  • Sumitomo Dainippon Pharma

Related Topics

Related Reports

Parkinson's disease psychosis - Pipeline Insight, 2024, - Product Image

Parkinson's disease psychosis - Pipeline Insight, 2024,

  • Clinical Trials
  • 60 Pages
  • Global
From
Schizophrenia Drugs Market Size, Share and Trends Analysis Report by Class (Second-Generation Antipsychotics, Third-Generation Antipsychotics, Others), Treatment, Distribution Channels, and Region 2024-2030 - Product Image

Schizophrenia Drugs Market Size, Share and Trends Analysis Report by Class (Second-Generation Antipsychotics, Third-Generation Antipsychotics, Others), Treatment, Distribution Channels, and Region 2024-2030

  • Report
  • 100 Pages
  • Global
From
Bipolar Disorder Market Size, Share & Trends Analysis Report By Type (Mood Stabilizer, Anticonvulsants, Antipsychotic Drugs), By Drug Class, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Bipolar Disorder Market Size, Share & Trends Analysis Report By Type (Mood Stabilizer, Anticonvulsants, Antipsychotic Drugs), By Drug Class, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Cannabis-Induced Psychosis (CIP) - Pipeline Insight, 2024 - Product Image

Cannabis-Induced Psychosis (CIP) - Pipeline Insight, 2024

  • Drug Pipelines
  • 60 Pages
  • Global
From
Schizophrenia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Schizophrenia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 185 Pages
  • Global
Copyright © 2002-2025 Research and Markets. All Rights Reserved.